Canberra needs to cut red tape to get medtech to consumers and keep innovation at home, MTA chief says.
Canberra needs to cut red tape to get medtech to consumers and keep innovation at home, MTA chief says.
End of content
No more pages to load
From The Source
- Imugene: Bile Tract Cancer Patient maintains Complete Response in MAST Study for Over Two Years
- Recce: Phase II ABSSSI Clinical Trial Advances to Final Stages
- DoHAC: Landmark report on how to unleash the potential of our health professions
- Albanese Government indefinitely DEFERS patient access to 44 medicines on PBS – Better Access Australia
- DoHAC: Unleashing the Potential of our Health Workforce – Scope of Practice Review Final Report
- PenCS adds operations and financial module to Practice Cloud
- DoHAC: First year of Medicare data shows increase to bulk billing
- Designs unveiled for Cessnock Hospital Redevelopment
- $250 million New Griffith Base Hospital on track for completion in 2025
- Latest data reveals NSW’s top melanoma hotspots
- Vic: Medicinal Cannabis Driving Trial Starts
- COVID-19 Response Inquiry – Statement from the Doherty Institute